Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

CVS Suit Against Prasco Illustrates Pricing Leverage From Caremark Merger

  • News

Executive Summary

A lawsuit by CVS Caremark against generic drug manufacturer Prasco illustrates the potential cross-market leverage that the combined pharmacy/PBM entity is able to wield

You may also be interested in...



CVS Caremark Takes Measured Approach In “Go To Market” Strategies

CVS Caremark is in the process of introducing new "cross-functional" products and services to its health plan clients, CEO Thomas Ryan said during the firm's second quarter earnings call Aug. 2

Express Scripts Tells Caremark Shareholders Vertical Mergers With PBMs Fail

A merger between pharmacy benefit manager Caremark and pharmacy chain CVS would be plagued by the same problems that vertical mergers involving PBMs have faced in the past, PBM Express Scripts argues in a pamphlet to Caremark shareholders

Orphan Drug Czar Will Push Legislators For More Grant Funding In 2008

For the past 15 years, funding for the grants program at FDA's Office of Orphan Products Development has remained stagnant at $14 million

Table

View full table

Tags:
Latest Headlines

Gene Therapy: Pediatric Development Could Start Sooner Than Sponsors Think – FDA OTP Director

Puberty Blockers: FDA's Califf Asked If REMS, Boxed Warning Against Off-Label Use In The Works

ADHD Drugs: FDA Commissioner Blames Inappropriate Prescribing For Shortages

Moment Of Truth For Seven EU Filings; Cytokinetics To Make Its Case For Heart Failure Drug

See All
UsernamePublicRestriction

Register

PS048787

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By